Swiss Research & Communication Network on Inflammatory Bowel Disease
Who we are
The IBDnet is a Swiss non-profit organisation led by medical specialists and scientists with emphasis in inflammatory bowel disease. As such, the IBDnet is a cooperation partner of the national society of gastroenterology, SGG. The scope of our organisation ranges from clinical reasearch, to continuing medical education, to facilitating clinical practice.
Beyond quality of care, we also focus on political issues around the approval and reimbursement of therapies.
Medical Education
Upcoming Events
We emphasize on improving quality of care by expanding your knowledge in IBD.
The COVID-related epidemiological situation remains tense to date, thus most of our educational events will be held as face-to-face meeting, if possible, and broadcasted at the same time. Furthermore, our past educational events have been recorded, we invite you to browse our education on-demand library in the member area.
Get an overview of all our educational activites in our Annual Event Calender 2024!
Education on demand
Annual Event Calender 2024
Get an overview of all our educational activites this year!
Nurse Education
Upcoming Events
The IBD nurse has a central role in the care of IBD patients. For more than a decade, we have been offering training for your IBD specialist nurse. We invite you to participate again this year.
Nurse Teaching Tutorials
Research to improve Quality of Care
Local research with global reach
The aim of IBDnet is to consolidate clinical IBD research in Switzerland as a research platform. Thus we do not only initiate and support local research projects with the help of grants, but also wish to be perceived as a partner for clinical research on an international level.
Swiss IBD Cohort Study - fully digital
Publications
Position Statements & Expert Recommendations
We are concerned at helping you to provide best care to your patients. Browse our local expert recommendations and position statments on IBD therapy.
Quality of care in 2020 and beyond
Position statement on the use of biosimilars
Position statement on the value of TDM
